Advanced Search
Contact | Corporate | Help

Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Sponsors:
  • Sarah Cannon Research Institute
  • Genentech
  • Novartis
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Prostate Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Erlotinib
  • Drug: Imatinib
Enrollment:
75

Additional information about NCT00193258.


SourceSolution © 2008-2012